novo nordisk glp-1 receptor agonist weight management diabetes treatments Agonists as for Type 2 GLP-1 receptor agonists | How
Description
J., Parkes, D., Feigh, M., Suschak, J
[DOI] [PubMed] [Google Scholar] 116.Buse J.B., Bain S.C., Mann J.F.E., Nauck M.A., Nissen S.E., Pocock S
Long-acting injectable GLP-1 receptor agonists for the treatment of adults with type 2 diabetes: perspectives from clinical practice
[2017] demonstrated that exenatide effectively reduced ICP in healthy rats within 10 minutes of subcutaneous administration
Glucagon-like peptide-1 protects hippocampal neurons against advanced glycation end product-induced tau hyperphosphorylation
Lee, C.-N
